Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001477932-25-001180
Filing Date
2025-02-21
Accepted
2025-02-21 15:11:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 23528
2 JOINT FILING AGREEMENT pembroke_ex994.htm EX-99 4169
  Complete submission text file 0001477932-25-001180.txt   29450
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Subject) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-89724 | Film No.: 25651130
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1345 AVENUE OF THE AMERICAS 27TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 27TH FLOOR NEW YORK NY 10105 212-813-1010
Pembroke & Partners LLC (Filed by) CIK: 0002056785 (see all company filings)

EIN.: 333245110 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D